Marilyn Boo
Marilyn is a gynaecological oncology fellow in the final months of subspecialty training at John Hunter Hospital and an ANZGOG Clinical Research Fellow, with research interests in perioperative care and survivorship in gynaecological cancer. She is actively involved in investigator-initiated trials including the currently recruiting GoROX trial, which is exploring rivaroxaban as an alternative option for postoperative VTE thromboprophylaxis. Her broader research interest lies in designing studies that are feasible, clinically meaningful, and aligned with value-based cancer care.
Abstracts this author is presenting:
